Nonepitopic antibody binding sequence: Implications in screening and development of peptide vaccines

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 315-320

  Adesida, Adetola B ^a   Aojula, Raj R ^b   Aojula, Harmesh S ^a   Clarke, David J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Peptide Products Ltd   (United Kingdom)

Author keywords

Nonepitopic sequences; Peptide vaccines; Polyclonal IgGs

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; PEPTIDE LIBRARY; SYNTHETIC PEPTIDE; VACCINE;

AMINO ACID SEQUENCE; ANTIGEN BINDING; CONFERENCE PAPER; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL; SCREENING;

ANTIGEN-ANTIBODY REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; PEPTIDE LIBRARY; PROTEIN BINDING; SEQUENCE ANALYSIS, PROTEIN; VACCINES, SYNTHETIC;

EID: 0032876568     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00210-8     Document Type: Conference Paper

References (13)

1. Castric P.A., Cassels F.J. Peptide epitope mapping in vaccine development. J. Ind. Microbiol. Biotech. 19:1997;56-57.
2. Hay F.C., Jones M.G., Soltys A., Horsfall A. British Society for Immunology - epitope mapping workshop. Immunol. Today. 14:1993;102-103.
3. Regenmortel M.H.V., Briand J.P., Muller S., Plaue S. Synthetic peptides as antigens. Burdon R.H., van Knippenberg P.H. Synthetic polypeptides as antigens. 1988;177 Elsevier, Oxford.
4. Akerstrom B., Bjorck L. Protein L: an immunoglobulin light chain-binding bacterial protein: characterization of binding and physiochemical properties. J. Biol. Chem. 264:(0-19746):1974;1989.
5. Akesson P., Cooney J., Kishimoto F., Bjorck L. Protein H - a novel IgG binding bacterial protein. Mol. Immunol. 27:1990;523-531.
6. Boyle M.D.P., Faulmann E.L., Metzger D.W. Applications of bacterial immunoglobulin-binding proteins to the purification of immunoglobulins. Ngo T.T. Molecular interactions in bioseparations. 1993;91 Plenum Press, New York.
7. Gomi H., Hozumi T., Hattori S., Tagawa C., Kishimoto F., Bjorck L. The gene sequence and some properties of protein H: a novel IgG-binding protein. J. Immunol. 144:1990;4046-4052.
8. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8A resolution. Biochem. 20:1981;2361-2370.
9. Derrick J.P., Wigley D.B. Crystal structure of a streptococcal protein G domain bound to an Fab fragment. Nature. 359:1992;752-754.
10. Braisted A.C., Wells J.A. Minimizing a binding domain from protein A. Proc. Natl Acad. Sci. USA. 93:1996;5688-5692.
11. Frick I., Wikstrom M., Forsen S., Drakenberg T., Gomi H., Sjobring U., Bjorck L. Convergent evolution among immunoglobulin G-binding bacterial proteins. Proc. Natl Acad. Sci., USA. 89:1992;8532-8536.
12. Merrifield R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:1963;2149-2154.
13. Batteiger B., Newhall V.W.J., Jones R.B. The use of Tween 20 as a blocking agent in immunological detection of proteins transferred to nitrocellulose membranes. J. Immunol. Methods. 55:1982;297-307.